{"version":"1.0","type":"link","title":"A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24).","author_name":"Kim M 외","author_url":"https://prs-insight.online/author/Kim%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/94976","thumbnail_width":1200,"thumbnail_height":630}